Josephine van Dongen

4 Rotavirus vaccine effectiveness 109 Med Hyg . Published online 2017. doi:10.4269/ajtmh.17-0705 21. Baxter D. Impaired functioning of immune defences to infection in premature and term infants and their implications for vaccination. Hum Vaccin . Published online 2010. doi:10.4161/hv.6.6.12008 22. Omenaca F, Sarlangue J, Szenborn L, et al. Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Preterm European Infants: A Randomized Phase IIIb Study. Pediatr Infect Dis J. 2012;31(5). doi:10.1097/INF.0b013e3182490a2c 23. Ciabattini A, Olivieri R, Lazzeri E, Medaglini D. Role of the microbiota in the modulation of vaccine immune responses. Front Microbiol . 2019;10(JUL). doi:10.3389/ fmicb.2019.01305 24. Chernikova DA, Madan JC, Housman ML, et al.The premature infant gut microbiome during the first 6 weeks of life differs based on gestational maturity at birth. Pediatr Res. 2018;84(1):71-79. doi:10.1038/s41390-018-0022-z 25. Lopez-Guerrero DV, Arias N, Gutierrez-Xicotencatl L, et al. Enhancement of VP6 immunogenicity and protective efficacy against rotavirus by VP2 in a genetic immunization. Vaccine . 2018;36(22):3072-3078. doi:10.1016/J.VACCINE.2017.03.104 26. Yeung KHT,Tate JE, Chan CC, et al. Rotavirus vaccine effectiveness in Hong Kong children. Vaccine. 2016;34(41):4935-4942. doi:10.1016/j.vaccine.2016.08.047 27. Grilli G, Levy-Bruhl D, Limia A, Mckeown P,Wiese-Posselt M. ECDC Exper t opinion on rotavirus vaccination in infancy. Eur Cent Dis Prev Control. Published online 2016. 28. Leshem E, Lopman B, Glass R, et al. Distribution of rotavirus strains and strain-spe- cific effectiveness of the rotavirus vaccine after its introduction: A systematic review and meta-analysis. Lancet Infect Dis . 2014;14(9):847-856. doi:10.1016/S1473-3099(14)70832-1 29. Schurink-van t Klooster TM, de Melker HE.The National Immmunisation Programme in the Netherlands: Surveillance and developments. Natl Inst Public Heal Environ . Published online 2019:102-125. doi:10.1007/978-94-6265-282-8_2 30. Middleton BF, Danchin M, Quinn H, Ralph AP. Rotavirus Epidemic in Rural and Re- mote Australia. Pathogens . 2020;9(790):1-12. 31. Pietsch C, Lieber t UG. Rotavirus vaccine effectiveness in preventing hospitalisations due to gastroenteritis. A descriptive epidemiological study from Germany. Clin Microbiol Infect . Published online April 2018. doi:10.1016/j.cmi.2018.03.046 32. Bruijning-Verhagen P, van Dongen JAP,Verberk JDM, et al. Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-en- demic setting. BMC Med . 2018;16(168). doi:10.1186/s12916-018-1134-3 33. Verberk JDM, Pijnacker R, Bruijning-Verhagen P, et al. Biennial Pattern of Ro- tavirus Gastroenteritis in The Netherlands and a Shifting Age Distribution Following a Low Rotavirus Season, 2010-2016. Pediatr Infect Dis J. 2018;37:248-250. doi:10.1097/ INF.0000000000001880